The editor is pleased to consider manuscripts on a wide range of topics related to the publication’s mission. All manuscripts and corresponding materials/documents must be submitted to the editor who oversees the publication. There are no fees or charges associated with submitting to or publishing your manuscript or paper in Pharmacy Times Oncology Edition™ (PTOE) or Pharmacy Times Health Systems Edition™ (HSE).
If you have questions about the manuscript submission process or wish to speak to an editor, please email Alana Hippensteele (firstname.lastname@example.org).
Manuscript submissions for each publication generally fall into one of the following content categories:
Requirements for all submissions conform to the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. By submitting your manuscript, you hereby guarantee that: (1) all sources used have been cited and listed in the references section; and (2) all necessary permissions have been obtained and credit properly given for content (ie, text and graphical items such as tables and figures) used in whole or part in the manuscript/eAppendix not considered to be original work.
1) AUTHOR DISCLOSURE FORM
All authors must read and sign the publication’s Author Disclosure Form. It is our policy to have all authors disclose relationships with any commercial interest that may present a conflict of interest if: (a) the relationship is financial and occurred within the past 12 months; and (b) the author discusses products or services of that commercial interest. Relevant financial relationships are those relationships in which the author (and/or the author's spouse or partner) benefits in any dollar amount by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (eg, stocks, stock options, or other ownership interests, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles, such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and/or other activities for which remuneration is received or expected. In addition, authors are required to report all financial and material support for their research, which includes (but is not limited to) grant support and funding sources and any provision of equipment or supplies.
The name of the organization funding or initiating a research project should be made explicit on the title page (eg, “This study was funded by the XYZ Corporation.”). Relevant financial relationships (whether direct to the authors or through a third party) for research and/or writing, including funding, grants, honoraria, etc, must also be named on the title page. If the funding organization had any role in the collection of data, its analysis and interpretation, and/or in the right to approve or disapprove publication of the finished manuscript, this must be noted in the cover letter and described in the Methods section of the text. The editorial staff may inquire further about financial disclosure after the manuscript is submitted. If the manuscript is accepted for publication, disclosure statements will be printed as part of the published article.
2) AUTHORSHIP FORM
All authors must read and sign the publication’s Authorship Form. PTOE and HSE use the criteria provided by the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to determine authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based only on substantial contributions to (a) conception and design, or analysis and interpretation of data; and to (b) drafting the article or revising it critically for important intellectual content; and on (c) final approval of the version to be published. All authors are required to read and sign the publication’s Authorship Form affirming that they have met the criteria for authorship and have agreed to transfer copyright to MJH Life Sciences®. Individuals who have contributed to a paper but who do not meet the criteria for authorship should be acknowledged.
Forms can also be sent to Alana Hippensteele, Managing Editor at email@example.com after submission. Please be sure to include the manuscript title, author names, and/or manuscript number in the email.
MANUSCRIPT PROCESSING AND PEER REVIEW
Acknowledgment of Receipt
Following submission of your manuscript or paper, editorial staff will respond confirming receipt before assessing whether the manuscript submission meets the publication’s specifications in terms of word count, blinded materials, and other guidelines, and will communicate any required changes to the authors.
Internal Review by Editor
Each manuscript is sent to the editor in chief for an internal evaluation to determine its appropriateness for the publication. Manuscripts that do not meet the publication’s criteria for overall appropriateness, relevance, originality, and scientific merit will be returned promptly (usually within 2 weeks) so that authors may pursue alternate avenues for publication.
Manuscripts deemed appropriate for the publication will be sent to external peer reviewers. Typically, a manuscript will be sent to a minimum of 2 reviewers who will be asked to provide feedback on the scientific merit and relevancy of the paper. The reviewer’s evaluation is requested back within 3 weeks.
Reviewer selection is ultimately the decision of the editorial team, but authors may suggest the names and email addresses of preferred/nonpreferred peer reviewers.
Criteria for Editorial Decisions
Manuscripts are judged on the interest/importance of the topic, the intellectual and scientific strength, the clarity of the presentation, and relevance to PTOE and HSE readers. The paper’s strength is compared with others under review and the number of accepted/previously published papers in the category. Original research and review articles should describe how their findings add to the existing literature.
Acceptance, Revision, or Rejection
Most authors can expect a first decision on their manuscript in approximately 2 months. However, we communicate editorial decisions on acceptance, revision, or rejection only to the corresponding author.
If the authors are offered the opportunity to revise their paper, the revision will be assessed by the editor in chief (and often the original peer reviewers) to confirm that the comments have been addressed.
All accepted papers require editorial revision and formatting before publication. An edited version of the manuscript in Microsoft Word will be sent to the corresponding author approximately 4 to 6 weeks before the issue date. Additionally, a final proof will be sent to the corresponding author for review before publication. Manuscript edits and final proofs must be returned to the editorial office within 48 hours.
By submitting a manuscript to PTOE or HSE, the authors confirm that the research meets ethical guidelines, including adherence to the legal requirements of the study country. Manuscripts submitted to PTOE or HSE that describe research on human subjects must include in the Methods section, a statement of institutional review board approval or exemption, and a confirmation that informed consent was obtained from study participants. Please see the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals for further details on protection of research participants.
EDITORIAL CONFLICTS OF INTEREST
Final decisions regarding manuscript publication are made by the editor in chief (EIC) of each publication. In the event that the EIC of PTOE or HSE has a conflict of interest with a submitted manuscript or the authors, the editorial decisions are made by the EIC of the sister publication—for PTOE this would be HSE, and for HSE this would be PTOE—who does not have a conflict of interest related to the manuscript or its authors.